xenon-pharma.com (XENE) - Kompaniya foydasi

XENE (Xenon) - kompaniyaning tovar belgisi

Xenon Pharmaceuticals (XENE) o'z laboratoriyalarida terapevtik samaradorlikka e'tibor qaratgan holda standart ekologik protokollarga rioya qiladi. Kompaniya miya ion kanallarini modulyatsiya qilish orqali epilepsiya uchun maqsadli davolash vositalarini ishlab chiqadi. Kompaniyaga tegishli sof foyda dinamikasi dori vositalarini ishlab chiqishni tezlashtirish uchun AI skriningini joriy etishga asoslangan va uning so'nggi ko'rsatkichi -0.40 ni tashkil etadi.

Kompaniyaning sof foydasi: xenon-pharma.com (XENE) 04.07.2022 - 31.10.2026 uchun

Xenon (XENE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Xenon Corp|XENE - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Xenon Corp|XENE - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati Xenon Pharmaceuticals|XENE - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati xenon-pharma.com|XENE - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Xenon Pharmaceuticals Inc.|XENE - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Xenon Corp|XENE - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Xenon Pharmaceuticals|Oraliq qoplash koeffitsiyenti xenon-pharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
XENE - Sof foyda
Kompaniyaning jamlanma tahlili:Xenon Corp (XENE)
Xenon Corp brend mahsuloti

Barqaror foyda o'sishi emitentning uzoq muddatli yashovchanligini namoyish etadi va barcha operatsion hamda soliq xarajatlari chegirilgandan keyingi sof moliyaviy qoldiqni o'lchaydi. Xenon Pharmaceuticals (XENE) moliyaviy natijalarini tahlil qilish R&D xarajatlarining samaradorligini kuzatish imkonini beradi, chunki biotexnologiya sektoridagi daromadlar bozor sikllari bilan emas, balki yangi dori vositalarining klinik sinov bosqichlarining muvaffaqiyatli yakunlanishi bilan bog'liqdir.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Sof daromad NBIX|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Viking Pharma VKTX|SUPN: Kompaniya foydasi|CPRX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Kompaniyaning sof foydasi|Kompaniya foydasi BHVN|Sof daromad AMLX|TRVI: Yakuniy foyda|Kompaniyaning sof foydasi Praxis Precision Medicines (PRAX)|AVXL: Soliqdan keyingi foyda|Sof foyda CBLL (CeriBell)|Yakuniy foyda PRTA|Alector Therapeutics - Sof foyda|ANNX - Sof foyda|omeros.com (OMER) - Kompaniyaning sof foydasi|neurogene.com - Yakuniy foyda|Kompaniyaning sof foydasi AC Immune SA|Sof daromad Voyager Therapeutics Inc (VYGR)|Sof foyda NMRA|Sof foyda Scilex Holding Company, Inc. (SCLX)|Sof foyda TVGN (Tevogen Bio Holdings)|ACOG - Sof daromad|Cognition Therapeutics - Sof foyda|Kompaniyaning sof daromadi Inhibikase Therapeutics Inc|SAVA (Cassava) - Sof daromad|Assertio (ASRT) - Sof foyda|Sof daromad COYA|VTGN (VistaGen Therapeutics Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda OVID|Sof moliyaviy natija Acumen Pharmaceuticals Inc.|Sof foyda CRVO (CervoMed Inc)|ATHE - Sof daromad|Clene Nanomedicine - Sof foyda|PEPG - Sof foyda|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|RLMD (Relmada Therapeutics Inc) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Annovis Bio Corp|Grace Tx (GRCE) - Sof moliyaviy natija|Sof daromad AIFF (Firefly Neuroscience, Inc)|anewmeds.com - Kompaniya foydasi|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Kompaniyaning sof daromadi|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof foyda ATHA|ADXN - Kompaniyaning sof daromadi|Alzamend Neuro - Sof daromad|Sof foyda Cyclerion Therapeutics Inc. CYCN|PTIX - Kompaniyaning sof foydasi|Yakuniy foyda KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Sof daromad BCLI|Kompaniya foydasi CARA (caratherapeutics.com)|Sof foyda CHRO|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH: Kompaniya foydasi|MRNS - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniya foydasi SAGE|Sof daromad SNPX|TRVN: Yakuniy foyda|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA: Soliqdan keyingi foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)